RenovoRx, Inc.

RNXT Nasdaq SEC CIK 1574094
Follow RenovoRx Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.1M +300.8% vs same quarter last year
Net income −$3.6M −25.2% vs same quarter last year
EPS, diluted −$0.08 +0% vs same quarter last year
Operating cash flow −$2.5M −11.9% vs same quarter last year
Revenue by quarter
$197K
$422K
$266K
$238K
$563K
$909K
$1.1M
Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
−$15M−$10M−$5M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$11.2M
FY24−$8.8M
FY23−$10.2M
FY22−$9.9M
FY21−$6.3M
FY20−$3.8M
FY19-